Patient, Author, and Postcast Host, Rylin Rossano, shares her support: because patients need answers now, not later. We’re stronger together. When we share our stories, we shine a light on invisible illnesses and push research forward for answers we all deserve.

CODA is proud to partner with other leading patient organizations in signing this letter to RECOVERY TLC leadership: https://t.co/RgKcyqaK8U #MECFS

Meet Kaelee, a resilient patient who can’t wait for answers. She knows research is the key to better treatments and brighter futures for millions with complex disorders. Together, we can turn hope into progress. Support research today: https://t.co/vYlvgqMFXv

Meet Sam! A remarkable patient on a mission to hike 50 miles for the CODA 50 Challenge! Sam knows firsthand how critical research is for proper treatment and care, and that’s why every mile matters. Support Sam and research for patients today! https://t.co/WtkBr7JvM7

We’re partnering with leading scientists in the neuroimmune space to bring patients the answers they need now. #patientscantwait Check it out here https://t.co/pGgQTp1NZh

We are currently at a Long Covid Hackathon with Dutch NL scientists to get new ideas for collaborative projects. 🤓🙃 We are wondering if bone marrow transplantations have been performed in a patient that also has long covid? What were the outcomes related to LC?

We're proud to serve as a sponsor of the @CellSymposia Neuro-immune Axis: Charting the Periphery Conference in partnership with the Allen Discovery Center for Neuroimmune Interactions & #neuroimmune innovator @itchdoctor. @amyrochlin @AllenInstitute https://t.co/1wPYrJZF3R

🚨The CODA 50 Challenge is LIVE!🚨 Run, walk, cycle or move 50 miles your way to fuel research for complex disorders. The first FIVE people to sign up for the CODA 50 Challenge will receive an exclusive CODA Thank You Gift! Don’t miss out! Join now at https://t.co/Jlu2gIqmz0

Molly is joining the CODA 50 Challenge for her sister, Grace, who can't wait. Join Molly in the CODA 50 Challenge to find solutions for patients today. Visit https://t.co/Ab3FD45rPb to join today.

As Gastroparesis Awareness Month comes to a close, we honor Lucy and the voice she brings to this community. Her story is a reminder of why we can't wait. Patients need answers, and research is the key. Together, we can push for progress.

Craniocervical dysfunction is common in complex disorders—yet rarely studied often under-treated. The CODA CCI Initiative is changing that. Your support today helps us move quickly and bring answers to patients. Help fund CODA CCI today: https://t.co/Przu5VS5YV

We’re thrilled to launch the CODA 50 Challenge—a run/walk/move-your-way fundraiser with a goal of raising $50,000 to power critical research for complex disorders The first FIVE people to sign up will receive a CODA Thank You Gift! Get started here: https://t.co/eCAhxZhyXF

Every day, CEO Amy Rochlin hears the same truth from patients: they can’t wait years for answers. CODA is driving research built on patient reality. Urgency is our mission. https://t.co/7SrvpM6dEx

Heather lives with Gastroparesis and CRPS. Her journey reminds us how deeply complex disorders intersect and why research that sees the bigger picture is urgently needed. Every patient story makes it clearer: these conditions are connected, and we can’t wait for answers.

Good news for dysautonomia patients w/ Sjogren's! Ianalumab is the 1st immunotherapy to have successful Phase 3 trials in Sjogren's, which means it has a real chance to obtain FDA approval. Sjogren's is the 2nd most common cause of autonomic neuropathy. https://t.co/qKrHC8FYNb

Cornell’s new study uses cell-free RNA to detect molecular differences in ME/CFS: immune dysregulation, ECM changes, T cell exhaustion. Our take: Early-stage model (~77% accuracy) is encouraging for future diagnostics. Why this hypothesis matters: Signals may reflect prolonged

This Gastroparesis Awareness Month we honor Caitlyn, a resilient patient who has used her battle to empower the patient community. CODA is fueling research we desperately need to find a cure, because no one should have to suffer in silence.

While you #sleep, your brain’s glymphatic system flushes out toxins, metabolic waste, and amyloid-β and tau, built up during the day. Glymphatic flow is highest during deep NREM sleep, when brain cells shrink up to 60%to create more space for fluid exchange. Hydration, regular

Wow, this interview with Professor Chris Ponting about the DecodeME findings has already had more than 1.5K views. He explains how the team found eight "genetic signals" related to the nervous system and immune function:

The latest paper from the Cornell ME/CFS Center is in PNAS today. RNA released into the blood differs in cases vs sedentary controls, who can be distinguished at 77% accuracy. Biological network analysis shows dysfunction of the immune system in ME/CFS, as in other assays.